Immuunhemolüüsiga

Immuunhemolüüsiga is a rare autoimmune disorder characterized by the presence of autoantibodies that cause the destruction of red blood cells. This process, known as hemolysis, leads to a decrease in the number of red blood cells and the production of hemoglobin. The condition is typically diagnosed in children and young adults, with symptoms including fatigue, pallor, shortness of breath, and abdominal pain. The exact cause of immuunhemolüüsiga is not fully understood, but it is believed to be triggered by an infection or vaccination, leading to the production of autoantibodies that attack the red blood cells.

The diagnosis of immuunhemolüüsiga is based on a combination of clinical symptoms, laboratory tests, and a blood smear examination. Treatment options include corticosteroids, immunosuppressants, and in some cases, splenectomy. The prognosis for immuunhemolüüsiga varies, with some patients experiencing a complete remission of symptoms, while others may require long-term management of the condition. The condition is relatively rare, with an estimated incidence of less than 1 in 100,000 people.